I recently got back from the European Psychiatric Association’s 2018 Congress – #EPA2018 (3-6 March) – which was in Nice this year. It was great to get away from snowy UK for a few days, and also to have some networking opportunities with UK and international colleagues. The strapline for this year’s event was “Integrate, Innovate, Individualise”, and nowhere was this more apparent than in the field of  adult ADHD.

An excellent satellite symposium brought together our Professor Philip Asherson, who spoke on “Guidelines for treatment of ADHD in Adults” with Anthony Rostain from the US and Larry Klassen from Canada, all talking about comorbidities, and the challenges of diagnosis in adult populations, where patients’ compensatory strategies and ability to choose their own environment can mask the “classic” ADHD symptoms completely, leaving issues with emotional dysregulation, sleep and substance misuse as the apparent issues.

There were also some excellent poster submissions and it was great to see Professor Susan Young also representing the UK. A fantastic few days, thanks to Shire for bringing everyone together.